Clinical features and surgical treatments of rare gastrointestinal stromal tumor spinal metastases

References

• Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259–69.
   PubMed Web of Science ®Google Scholar
• Miettinen M, Lasota J. Gastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1–12.
   PubMed Web of Science ®Google Scholar
• Burkill GJ, Badran M, Al-Muderis O, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 2003;226:527–32.
   PubMed Web of Science ®Google Scholar
• Soreide K, Sandvik OM, Soreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol 2016;40:39–46.
   PubMed Web of Science ®Google Scholar
• Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999;30:1213–20.
   PubMed Web of Science ®Google Scholar
• Di Scioscio V, Greco L, Pallotti MC, et al. Three cases of bone metastases in patients with gastrointestinal stromal tumors. Rare Tumors 2011;3:e17–53.
   PubMedGoogle Scholar
• Jain A, Dubashi B, Mangaladevi Chandra SS, Halanaik D. Mesentric gastrointestinal stromal tumor with bone metastases. Indian J Cancer 2011;48:383–4.
   PubMed Web of Science ®Google Scholar
• Feki J, Bouzguenda R, Ayedi L, et al. Bone metastases from gastrointestinal stromal tumor: a case report. Case Rep Oncol Med 2012;2012:509845.
   PubMedGoogle Scholar
• Jati A, Tatli S, Morgan JA, et al. Imaging features of bone metastases in patients with gastrointestinal stromal tumors. Diagn Interv Radiol 2012;18:391–6.
   PubMed Web of Science ®Google Scholar
• Sahin E, Yetisyigit T, Oznur M, Elboga U. Gastric gastrointestinal stromal tumor with bone metastases – case report and review of the literature. Klin Onkol 2014;27:56–9.
   PubMedGoogle Scholar
• Slimack NP, Liu JC, Koski T, Mcclendon J, Jr., O’shaughnessy BA. Metastatic gastrointestinal stromal tumor to the thoracic and lumbar spine: first reported case and surgical treatment. Spine J 2012;12:e7–12.
   PubMed Web of Science ®Google Scholar
• Waterman BR, Kusnezov N, Dunn JC, Hakim MN. Aggressive gastrointestinal stromal tumor with spinal metastases: a case report. Mil Med 2015;180:e618–21.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Murakami H, Sangsin A, et al. En bloc corpectomy for late gastrointestinal stromal tumor metastasis: a case report and review of the literature. J Med Case Rep 2018;12:300.
   PubMedGoogle Scholar
• Schuler M, Zeile M, Pink D, et al. Incidence of bone metastases in GIST: a single center analysis of 307 patients with metastatic disease. J Clin Oncol 2008;26:10565.
   Web of Science ®Google Scholar
• Agaimy A, Wunsch PH, Hofstaedter F, et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 2007;31:113–20.
   PubMed Web of Science ®Google Scholar
• Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459–65.
   PubMed Web of Science ®Google Scholar
• Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004;22:3813–25.
   PubMed Web of Science ®Google Scholar
• Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 2004;11:465–75.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Fiore M, Miselli F, et al. Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST. Ann Surg 2007;245:341–6.
   PubMed Web of Science ®Google Scholar
• Joensuu H. Sunitinib for imatinib-resistant GIST. Lancet 2006;368:1303–4.
   PubMed Web of Science ®Google Scholar
• Heinrich MC, Maki RG, Corless CL, et al. Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. J Clin Oncol 2008;26:5352–9.
   PubMed Web of Science ®Google Scholar
• Hoefert S, Eufinger H. Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:463–9.
   PubMed Web of Science ®Google Scholar
• Nicolatou-Galitis O, Migkou M, Psyrri A, et al. Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:234–8.
   PubMed Web of Science ®Google Scholar
• Joensuu H, Eriksson M, Collan J, Balk MH, Leyvraz S, Montemurro M. Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: a prospective study. Radiother Oncol 2015;116:233–8.
   PubMed Web of Science ®Google Scholar